The RTS, S/AS01 vaccine continues to show modest protection against malaria in African infants and children

PJ Rosenthal - BMJ Evidence-Based Medicine, 2015 - ebm.bmj.com
Methods In this phase III double-blind trial, 6537 infants (aged 6–12 weeks) and 8922
children (aged 5–17 months) were enrolled at 11 centres in seven countries, from 2009 to …
被引用次数：8 相关文章

[引用][C] The RTS, S/AS01 vaccine continues to show modest protection against malaria in African infants and children

PJ Rosenthal - Evidence-based medicine, 2015 - pubmed.ncbi.nlm.nih.gov

[引用][C] The RTS, S/AS01 vaccine continues to show modest protection against malaria in African infants and children.

PJ Rosenthal - Evidence-based Medicine, 2015 - europepmc.org
The RTS,S/AS01 vaccine continues to show modest protection against malaria in African
infants and children. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

The RTS, S/AS01 vaccine continues to show modest protection against malaria in African infants and children

PJ Rosenthal - BMJ Evidence-Based Medicine, 2015 - search.proquest.com
Context Malaria remains one of the greatest infectious burdens in the world. 1 The RTS, S
vaccine results from decades of research showing that human responses to the Plasmodium …

The RTS, S/AS01 vaccine continues to show modest protection against malaria in African infants and children

PJ Rosenthal - BMJ Evidence-Based Medicine, 2015 - ebm.bmj.com
Methods In this phase III double-blind trial, 6537 infants (aged 6–12 weeks) and 8922
children (aged 5–17 months) were enrolled at 11 centres in seven countries, from 2009 to …